Harvard Bioscience (HBIO) Misses Q1 EPS by 1c

Harvard Bioscience (NASDAQ: HBIO) reported Q1 EPS of $0.04, $0.01 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $28.8 million versus the consensus estimate of $28.77 million.

For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c